Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Dec 2;9:18021. doi: 10.1038/s41598-019-54226-7

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

pH-dependent FcRn binding properties. Binding to a constant amount of GST-tagged human FcRn (1 µg/mL) at pH 5.5 and pH 7.2 for titrated amounts (1000–0.5 ng/mL) of (a) aflibercept and (b) bevacizumab at D0 (black and dark green) and D7 (blue and light green). Comparison of binding to human FcRn at D0 (black) and D7 (blue) at a given concentration of 111 ng/mL aflibercept (c) and bevacizumab (d). For each sample set n = 6. The unpaired Student’s t-test was used for statistical analysis.